|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| In-process research and development expenses | |||||
| Stock-based compensation | |||||
| Deferred income taxes | |||||
| Provision for credit loss recovery | |||||
| Loss on disposal of property and equipment | |||||
| Loss on impairment of asset | |||||
| Loss on debt extinguishment | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable, net | |||||
| Inventory, net | |||||
| Prepaid expenses and other | |||||
| Other current assets | |||||
| Accounts payable | |||||
| Operating lease assets and liabilities, net | |||||
| Accrued expenses and other | |||||
| Deferred tax assets | |||||
| Post-marketing commitment liability | |||||
| Net cash provided by operating activities | |||||
| Investing activities: | |||||
| Purchase of property and equipment | |||||
| Acquired in-process research and development | |||||
| Purchase of available-for-sale securities | |||||
| Maturity of available-for-sale securities | |||||
| Purchase of intangible assets | |||||
| Net cash used in investing activities | |||||
| Financing activities: | |||||
| Net proceeds from shares issued under employee stock plans | |||||
| Gross proceeds from private investments in public equity | |||||
| Issuance costs associated with private investments in public equity | |||||
| Proceeds from debt | |||||
| Payment of debt | |||||
| Payment of prepayment costs, end of loan payment and other extinguishment costs | |||||
| Payment of debt issuance costs | |||||
| Installment payment for purchase of intangible asset | |||||
| Payment of exit costs | |||||
| Net cash used in financing activities | |||||
| Net (decrease) increase in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of period | |||||
| Cash, cash equivalents and restricted cash, end of period | |||||
| Supplemental disclosures of non-cash investing and financing activities: | |||||
| Intangibles in accrued in-license rights | |||||
| Property and equipment purchases in accounts payable | |||||
| Supplemental disclosure of cash flow information: | |||||
| Interest paid | |||||
| Income taxes paid | |||||
Loading...